Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 15,953 | 0 | N/A | N/A |
| Receivables | 3,832 | 0 | N/A | N/A |
| Other current assets | 1,328 | 0 | 0 | 0 |
| TOTAL | $24,306 | $0 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3,502 | 0 | N/A | N/A |
| Investments And Advances | 7,626 | 0 | 0 | 0 |
| Other Non-Current Assets | 612 | 0 | 0 | 0 |
| TOTAL | $11,740 | $N/A | $N/A | $N/A |
| Total Assets | $36,046 | $0 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,601 | 0 | 0 | 0 |
| Accrued Expenses | 8,973 | 0 | N/A | N/A |
| Other current liabilities | 654 | 0 | N/A | N/A |
| TOTAL | $12,389 | $0 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 161 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 4,679 | 0 | 0 | 0 |
| TOTAL | $5,771 | $N/A | $N/A | $N/A |
| Total Liabilities | $18,160 | $0 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | 0 | N/A | N/A |
| Retained earnings | -30,871 | 0 | N/A | N/A |
| Other shareholders' equity | 41,323 | 0 | 0 | 0 |
| TOTAL | $17,886 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $36,046 | $0 | $0 | $0 |